Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
Minfeng Cheng,* Huaying Gu,* Liangrong Zheng, Houliang Wang, Zhiyong Zhong, Shenglin Wen Department of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China *These authors contributed equally to this work Abstract: Here, we repor...
Guardado en:
Autores principales: | Cheng MF, Gu HY, Zheng LR, Wang HL, Zhong ZY, Wen SL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7ef09e2ad1049538b8fff79fb4ba05b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Síndrome neuroléptico maligno y poliserositis en paciente usuaria de clozapina: una asociación infrecuente
por: Eymin L,Gonzalo, et al.
Publicado: (2005) -
Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
por: Miguel Santos, et al.
Publicado: (2021) -
Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19
por: Fitri Fareez Ramli, et al.
Publicado: (2021) -
Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia
por: Amina Aissa, et al.
Publicado: (2022) -
Neuroleptic malignant syndrome: an easily overlooked neurologic emergency
por: Oruch R, et al.
Publicado: (2017)